News | November 21, 2025
EMA launches streamlined process to fast-track critical medicines, vaccines
The move is expected to be crucial during health crises
The move is expected to be crucial during health crises
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
Phase 3 program for NDV-01 in non-muscle invasive bladder cancer expected to begin in the first half of 2026
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
India currently hosts more than 10,075 biotech startups
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
RTX001 represents a groundbreaking advance in the treatment of end-stage liver disease, offering new hope for patients with limited options
LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
Guidelines aim to establish state-regulated veterinary blood banks
Subscribe To Our Newsletter & Stay Updated
